Ecolab Inc. (ECL) said that it has entered into an agreement with AvidBiotics Corp. under which they will jointly work to develop a new technology that could significantly reduce the presence of the pathogen E. coli O157:H7 in red meat products.
The companies' intent is to successfully commercialize AvidBiotics' proprietary protein-based antibacterial technology, which can be targeted against specific bacterial pathogens. While this platform technology may be applicable to numerous food pathogens, the companies are first targeting the food pathogen E. coli in red meat.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.